Trial intelligence / Profile preview

DAY101 in Pediatric BRAF-Altered Recurrent or Progressive Low-Grade Glioma

2020-003657-30Phase 2

Sponsor

DOT Therapeutics-1 Inc. (Day One)

Start

Oct 2020

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1